Therapeutic opportunities within the DNA damage response
Pearl, Laurence H., Schierz, Amanda C., Ward, Simon E., Al-Lazikani, Bissan, Pearl, Frances M. G.·2015·Nature Reviews Cancer
DOI 10.1038/nrc3891
Cited by (578)
Items 101–200 of 578
- Modification of DNA Checkpoints to Confer Aluminum ToleranceThomas Eekhout, Paul B. Larsen, Lieven De Veylder · 2017 · Trends in Plant Science
- Inhibition of NADPH Oxidase-ROS Signal using Hyaluronic Acid Nanoparticles for Overcoming Radioresistance in Cancer TherapyLei Zhu, Yi Zhao, Tongrui Liu, Minglong Chen, Wei Ping Qian, Bing‐Hua Jiang, Benjamin G. Barwick, Lumeng Zhang, Toncred Marya Styblo, Xiaoxian Li et al. · 2022 · ACS Nano
- Translational research in radiation-induced DNA damage signaling and repairJac A. Nickoloff, Mary‐Keara Boss, Chris Allen, Susan Μ. LaRue · 2017 · Translational Cancer Research
- Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancerXiaofei Zhang, Tiebo Mao, Bei Zhang, Haiyan Xu, Jiujie Cui, Feng Jiao, Dongqin Chen, Yu Wang, Jiong Hu, Qing Xia et al. · 2022 · EBioMedicine
- Opportunities for Therapeutic Modulation of O-GlcNAcSteven S. Cheng, Alison C. Mody, Christina M. Woo · 2024 · Chemical Reviews
- MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal CancerYiling Situ, Liping Chung, Cheok Soon Lee, Vincent Ho · 2019 · International Journal of Molecular Sciences
- Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal CancerErika Durinikova, Nicole Megan Reilly, Kristi Buzo, Elisa Mariella, Rosaria Chilà, Annalisa Lorenzato, João M.L. Dias, Gaia Grasso, Federica Pisati, Simona Lamba et al. · 2022 · Clinical Cancer Research
- Predicting and Overcoming Chemotherapeutic Resistance in Breast CancerKyung‐Hee Chun, Jong Hoon Park, Siting Fan · 2017 · Advances in experimental medicine and biology
- DNA damage and repair measured by comet assay in cancer patientsPavel Vodička, Soňa Vodenková, Alena Opattová, Ľudmila Vodičková · 2019 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
- Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cellsJaslyn Sian-Siu Soo, Char‐Hong Ng, Si Hoey Tan, Rozita Abdul Malik, Yew-Ching Teh, Boon-Shing Tan, Gwo Fuang Ho, Mee‐Hoong See, Nur Aishah Mohd Taib, Cheng Har Yip et al. · 2015 · APOPTOSIS
- DNA folds threaten genetic stability and can be leveraged for chemotherapyJoanna Zell, Francesco Rota Sperti, Sébastien Britton, David Monchaud · 2020 · RSC Chemical Biology
- Total Synthesis and Target Identification of the Curcusone DiterpenesChengsen Cui, Brendan G. Dwyer, Chang Liu, Daniel Abegg, Zhong-Jian Cai, Dominic G. Hoch, Xianglin Yin, Nan Qiu, Jie‐Qing Liu, Alexander Adibekian et al. · 2021 · Journal of the American Chemical Society
- Metal nanoparticles for cancer therapy: Precision targeting of DNA damageQian Chen, Chunyan Fang, Fan Xia, Qiyue Wang, Fangyuan Li, Daishun Ling · 2023 · Acta Pharmaceutica Sinica B
- DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategiesMohammad Mirza‐Aghazadeh‐Attari, Caspian Ostadian, Amir Ata Saei, Ainaz Mihanfar, Saber Ghazizadeh Darband, Shirin Sadighparvar, Mojtaba Kaviani, Hossein Samadi Kafil, Bahman Yousefi, Maryam Majidinia · 2019 · DNA repair
- The whole-genome panorama of cancer driversRadhakrishnan Sabarinathan, Oriol Pich, Iñigo Martincorena, Carlota Rubio-Pérez, Malene Juul, Jeremiah A. Wala, Steven E. Schumacher, Ofer Shapira, Nikos Sidiropoulos, Sebastian M. Waszak et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
- Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancerChristopher D. Heinen · 2015 · DNA repair
- Xenopus egg extract: A powerful tool to study genome maintenance mechanismsWouter S. Hoogenboom, Daisy Klein Douwel, Puck Knipscheer · 2017 · Developmental Biology
- Targeting DNA damage in SCLCVictoria Foy, Maximilian W. Schenk, Katie Baker, Fábio Gomes, Alice Lallo, Kristopher K. Frese, Martin David Forster, Caroline Dive, Fiona Helen Blackhall · 2017 · Lung Cancer
- Regulators in the DNA damage responseYunhua Liu, Yujing Li, Xiongbin Lu · 2016 · Archives of Biochemistry and Biophysics
- Harnessing DNA Replication Stress for Novel Cancer TherapyHuanbo Zhu, Umang Swami, Ranjan Preet, Jun Zhang · 2020 · Genes
- Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase ThetaMartin L. Stockley, Amanda Ferdinand, Giovanni Benedetti, Peter Blencowe, Susan M. Boyd, Mat Calder, Mark D. Charles, Lucy V. Edwardes, Tennyson Ekwuru, Harry Finch et al. · 2022 · Journal of Medicinal Chemistry
- Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminasesJoseph Chi-Fung Ng, Jelmar Quist, Anita E. Grigoriadis, Michael H. Malim, Franca Fraternali · 2019 · Nucleic Acids Research
- Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and SelectivityUday Kiran Velagapudi, Marie-France Langelier, Cristina Delgado-Martín, Morgan E. Diolaiti, Sietske T. Bakker, Alan Ashworth, Bhargav A. Patel, Xuwei Shao, John M. Pascal, Tanaji T. Talele · 2019 · Journal of Medicinal Chemistry
- Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performanceAnne Ramsay Bowden, David A. Morales-Juarez, Matylda Sczaniecka-Clift, Maria Martin Agudo, Natalia Lukashchuk, John Christopher Thomas, Stephen P. Jackson · 2020 · eLife
- A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityXiaojie Xu, Zhongyi Fan, Chaoyang Liang, Ling Li, Lili Wang, Yingchun Liang, Jun Wu, Shaohong Chang, Zhifeng Yan, Zhaohui Lv et al. · 2017 · Nature Communications
- XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistanceSitian Yang, Xiao Qi Wang · 2017 · BMC Cancer
- Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathwayOzan Alkan, Birgit Schoeberl, Millie Shah, Alexander Koshkaryev, Tim Heinemann, Daryl C. Drummond, Michael B. Yaffe, Andreas Raue · 2018 · Science Signaling
- Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assemblyElisa Fadda · 2015 · Computational and Structural Biotechnology Journal
- Cross-regulation between Notch signaling pathway and miRNA machinery in cancerMaryam Majidinia, Saber Ghazizadeh Darband, Mojtaba Kaviani, Seyed Mohammad Nabavi, Rana Jahanban‐Esfahlan, Bahman Yousefi · 2018 · DNA repair
- Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP InhibitorsChenxi Wang, Zi-Lin Zhang, Qikun Yin, Jia-Li Tu, Jia-En Wang, Yao‐Hao Xu, Yong Rao, Tian‐Miao Ou, Shi‐Liang Huang, Ding Li et al. · 2020 · Journal of Medicinal Chemistry
- An RNA damage response network mediates the lethality of 5-FU in colorectal cancerJung-Kuei Chen, Karl A. Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George M. Eng, Erika D. Handly, Jesse Christopher Patterson, Ian Gordon Cannell, Lucía Suárez-López, Aaron M. Hosios et al. · 2024 · Cell Reports Medicine
- The role of cancer stem cells in tumor heterogeneity and resistance to therapyChristina Valbirk Konrad, Reshma Murali, Binitha Anu Varghese, Radhika Nair · 2016 · Canadian Journal of Physiology and Pharmacology
- Targeting of stress response pathways in the prevention and treatment of cancerJaroslav Zelenka, Martina Koncošová, Tomáš Ruml · 2018 · Biotechnology Advances
- Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza A viral infectionHeeju Noh, Jason E. Shoemaker, Rudiyanto Gunawan · 2017 · Nucleic Acids Research
- Systematic discovery of germline cancer predisposition genes through the identification of somatic second hitsSolip Park, Fran Supek, Ben Lehner · 2018 · Nature Communications
- Management and Treatment of Recurrent Epithelial Ovarian CancerShannon Dawn Armbruster, Robert Louis Coleman, Jose Alejandro Rauh‐Hain · 2018 · Hematology/Oncology Clinics of North America
- Mitochondrial DNA damage, repair, and replacement in cancerPavel Vodička, Soňa Vodenková, Natalie Danesova, Ludmila Vodičková, Renata Zobalová, Kristýna Tomášová, Štěpána Boukalová, Michael V. Berridge, Jiřı́ Neužil · 2024 · Trends in cancer
- Improving survival in molecularly selected glioblastomaRoger Stupp, Rimas Vincas Lukas, Monika E. Hegi · 2019 · The Lancet
- Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cellsSang-Han Lee, Yoon‐Jin Lee · 2021 · Nutrition Research and Practice
- A Single‐Stranded DNA‐Encoded Chemical Library Based on a Stereoisomeric Scaffold Enables Ligand Discovery by Modular Assembly of Building BlocksGabriele Bassi, Nicholas Favalli, Miriam Vuk, Marco Catalano, Adriano Luca Martinelli, Anika Trenner, Antônio Porro, Su Yang, Chuin Lean Tham, Mustafa Moroglu et al. · 2020 · Advanced Science
- Targeting the DNA Damage Response for Cancer TherapyRuoxi Wang, Yating Sun, Chunshuang Li, Yaoyao Xue, Xueqing Ba · 2023 · International Journal of Molecular Sciences
- The DNA damage response pathway in normal hematopoiesis and malignanciesDomenico Delia, Shuki Mizutani · 2017 · International Journal of Hematology
- Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer PatientsPavel Vodička, Markéta Urbanová, Pavol Makovický, Kristýna Tomášová, Michal Kroupa, Rudolf Štětina, Alena Opattová, Klara Kostovcikova, Anna Siskova, Michaela Schneiderová et al. · 2020 · International Journal of Molecular Sciences
- Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapyJac A. Nickoloff, Lynn Taylor, Neelam Sharma, Takamitsu A. Kato · 2021 · Cancer Drug Resistance
- Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiologyMartina Magni, Giacomo Buscemi, Laura Zannini · 2018 · Mutation Research/Reviews in Mutation Research
- DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy OutcomeKristýna Tomášová, Andrea Čumová, Karolína Šeborová, Josef Horak, Kamila Koucká, Ľudmila Vodičková, Radka Václavíková, Pavel Vodička · 2020 · Cancers
- Pan-Cancer Analysis Reveals Synergistic Effects of CDK4/6i and PARPi Combination Treatment in RB-Proficient and RB-Deficient Breast Cancer CellsSongyu Li, Yixiang Zhang, Na Wang, Rong Guo, Qiaoling Liu, Changsheng Lv, Jinguang Wang, Lina Wang, Qingkai Yang · 2018 · Cell Death and Disease
- Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATMJennifer Ma, Jeremy S. Setton, Luc G.T. Morris, Pedro Blecua, Christopher Andrew Barker, Benjamin H. Lok, Eric Jeffrey Sherman, Nora Katabi, Kathryn P. Beal, Ian Ganly et al. · 2016 · Oncotarget
- The DNA damage checkpoint: A tale from budding yeastPaolo Pizzul, Erika Casari, Marco Gnugnoli, Carlo Rinaldi, Flavio Corallo, Maria Pia Longhese · 2022 · Frontiers in Genetics
- Oxidative Damage Induces a Vacancy G-Quadruplex That Binds Guanine Metabolites: Solution Structure of a cGMP Fill-in Vacancy G-Quadruplex in the Oxidized BLM Gene PromoterKai‐Bo Wang, Yushuang Liu, Yipu Li, Jonathan Dickerhoff, Jinzhu Li, Ming-Hua Yang, Danzhou Yang, Lingyi Kong · 2022 · Journal of the American Chemical Society
- DNA damage response signaling: A common link between cancer and cardiovascular diseasesSepideh Nikfarjam, Krishna Kumar Singh · 2022 · Cancer Medicine
- Cellular Responses to Widespread DNA Replication StressJac A. Nickoloff, Aruna Shanker Jaiswal, Neelam Sharma, Elizabeth A. Williamson, Manh Tien Tran, Dominic Arris, Ming Yang, Robert Hromas · 2023 · International Journal of Molecular Sciences
- TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1Mohammad Belayat Hossain, Rehnuma Shifat, David G. Johnson, Mark T. Bedford, Konrad R. Gabrusiewicz, Nahir Cortes‐Santiago, Xuemei Luo, Zhimin Lu, Ravesanker Ezhilarasan, Erik P. Sulman et al. · 2016 · Science Advances
- Targeting DNA Damage Response and Immune Checkpoint for Anticancer TherapyHuang, Jau-Ling, Chang, Yu-Tzu, Hong, Zhen-Yang, Lin, Chang-Shen · 2022 · International Journal of Molecular Sciences
- Pentagalloylglucose disrupts the PALB2-BRCA2 interaction and potentiates tumor sensitivity to PARP inhibitor and radiotherapyJie Zeng, Jichang Han, Zhaorui Liu, Yu Meng, Hao Li, Jianzhong Yu · 2022 · Cancer Letters
- Hereditary cancer variants and homologous recombination deficiency in biliary tract cancerYuki Okawa, Yusuke Iwasaki, Todd A. Johnson, Nobutaka Ebata, Chihiro Inai, Mikiko Endo, Kazuhiro Maejima, Shota Sasagawa, Masashi Fujita, Koichi Matsuda et al. · 2022 · Journal of Hepatology
- Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular CellsHuan Liu, Wenchao Zhang, Lijie Jin, Shasha Liu, Liying Liang, Yanfei Wei · 2023 · International Journal of Molecular Sciences
- Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilitiesChao Chen, Cai‐Jin Lin, Yu‐Chen Pei, Ding Ma, Li Liao, Si‐Yuan Li, Lei Fan, Gen‐Hong Di, Song‐Yang Wu, Xiyu Liu et al. · 2023 · Cell Discovery
- Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during 177Lu/225Ac treatment in neuroendocrine tumors and metastatic prostate cancerHabibollah Dadgar, Ali Pashazadeh, Nasim Norouzbeigi, Majid Assadi, Batool Albalooshi, Richard P. Baum, Akram Al‐Ibraheem, Mohamad Haidar, Mohsen Beheshti, Parham Geramifar et al. · 2025 · Theranostics
- Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and CarcinogenesisJorge Luis Espinoza, Mika Minami · 2018 · Frontiers in Immunology
- A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choiceParis Roidos, Stéphanie Sungalee, Salvatore Benfatto, Özdemirhan Serçin, Adrian M. Stütz, Amir Abdollahi, Jan Mauer, Frank T. Zenke, Jan O. Korbel, Balca R. Mardin · 2020 · Nature Communications
- MicroRNAs and Cancer Drug ResistanceBruno Costa Gomes, José Rueff, António Sebastião Rodrigues · 2016 · Methods in molecular biology
- Proteome Stability as a Key Factor of Genome IntegritySentiljana Gumeni, Zoi Evangelakou, Vassilis G. Gorgoulis, Ioannis P. Trougakos · 2017 · International Journal of Molecular Sciences
- Fluorescent Probes of DNA RepairDavid L. Wilson, Eric T. Kool · 2017 · ACS Chemical Biology
- Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferationJan Stetka, Pavla Vyhlidalova, Lucie Lanikova, Pavla Kořalková, Ján Gurský, A. Hlusi, Patrik Flódr, Soňa Hubáčková, Jiří Bártek, Zdeněk Hodný et al. · 2019 · Oncogene
- Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distributionJin‐Xue He, Meng Wang, Xia‐Juan Huan, Chuan‐Huizi Chen, Shanshan Song, Ying-Qing Wang, Xue-Mei Liao, Cun Tan, Qian He, Linjiang Tong et al. · 2016 · Oncotarget
- CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactionsDan Su, Xu Feng, Medina Colic, Yunfei Wang, Chunchao Zhang, Chao Wang, Mengfan Tang, Traver Hart, Junjie Chen · 2020 · DNA repair
- Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical dataElodie Chartron, Charles G. Theillet, Séverine Guiu, William Jacot · 2018 · Critical Reviews in Oncology/Hematology
- Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancerYongchen Ma, Jing Zhu, Shanwen Chen, Ju Ma, Xiaoqian Zhang, Sixia Huang, Jianwen Hu, Taohua Yue, Junling Zhang, Pengyuan Wang et al. · 2019 · Cancer Cell International
- DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapiesOla Rominiyi, Spencer James Collis · 2021 · Molecular Oncology
- Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment ScreeningFrancesca Ester Morreale, Alessio Bortoluzzi, Viduth K. Chaugule, Connor Arkinson, Helen Walden, Alessio Ciulli · 2017 · Journal of Medicinal Chemistry
- BRCT domains of the DNA damage checkpoint proteins TOPBP1/Rad4 display distinct specificities for phosphopeptide ligandsM.W. Day, Mathieu Rappas, Katie Ptasińska, Dominik Boos, Antony W. Oliver, Laurence H. Pearl · 2018 · eLife
- The impact of rare germline variants on human somatic mutation processesMischan Vali-Pour, Solip Park, Jose Espinosa‐Carrasco, Daniel Ortiz-Martínez, Ben Lehner, Fran Supek · 2022 · Nature Communications
- Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2Péter Hornyák, Trevor Askwith, Sarah Walker, Emilia Komulainen, Michael Paradowski, Lewis E. Pennicott, Edward J. Bartlett, Nigel C. Brissett, Ali Raoof, Mandy Watson et al. · 2016 · Biochemical Journal
- Cancer Chemoradiotherapy Duo: Nano-Enabled Targeting of DNA Lesion Formation and DNA Damage ResponseWei Jiang, Quan Li, Zhengchun Zhu, Qin Wang, Jiaxiang Dou, Yingming Zhao, Weifu Lv, Fei Zhong, Yandan Yao, Guoqing Zhang et al. · 2018 · ACS Applied Materials & Interfaces
- G Protein-Coupled Receptor Systems as Crucial Regulators of DNA Damage Response ProcessesHanne Leysen, Jaana van Gastel, Jhana O. Hendrickx, Paula Santos‐Otte, Bronwen Martin, Stuart R. Maudsley · 2018 · International Journal of Molecular Sciences
- Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomasJing Wang, Ruiyu Li, Yangzhige He, Yuting Yi, Huanwen Wu, Zhiyong Liang · 2020 · Modern Pathology
- RETRACTED: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin SignalingLing Wang, Xiaoke Chai, Run Wan, Hong Zhang, Cong Zhou, Xiang Lin, Maswikiti Ewetse Paul, Yumin Li · 2020 · Frontiers in Oncology · Retracted
- Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promisesMelissa M. Pham, Natalie Y.L. Ngoi, Guang Peng, David S.P. Tan, Timothy Anthony Yap · 2021 · Trends in cancer
- DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung CancerJiawei Dai, Minlin Jiang, Kan He, Hao Wang, Peixin Chen, Haoyue Guo, Wencheng Zhao, Hui Juan Lu, Yayi He, Caicun Zhou · 2021 · Frontiers in Oncology
- Targeted photodynamic therapy in visible light using BODIPY-appended copper( ii ) complexes of a vitamin B 6 Schiff baseNandini Mukherjee, Santosh Podder, Koushambi Mitra, Shamik Majumdar, Dipankar Nandi, Akhil Ranjan Chakravarty · 2017 · Dalton Transactions
- Genetic vulnerabilities upon inhibition of DNA damage responseChao Wang, Mengfan Tang, Zhen Chen, Litong Nie, Siting Li, Yun Xiong, Klaudia Szymonowicz, Jeong-Min Park, Huimin Zhang, Xu Feng et al. · 2021 · Nucleic Acids Research
- Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethalitySalvatore Benfatto, Özdemirhan Serçin, Francesca R. Dejure, Amir Abdollahi, Frank T. Zenke, Balca R. Mardin · 2021 · Molecular Cancer
- Sex disparities in DNA damage response pathways: Novel determinants in cancer formation and therapyMiriana Cardano, Giacomo Buscemi, Laura Zannini · 2022 · iScience
- A multi-scale map of protein assemblies in the DNA damage responseAnton Kratz, Minkyu Kim, Marcus R. Kelly, Fan Zheng, Christopher A. Koczor, Jianfeng Li, Keiichiro Ono, Yue Qin, Christopher Churas, Jing Chen et al. · 2023 · Cell Systems
- Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry StudyPaul McNulty, Richard Pilcher, Raviram Ramesh, Renata Necuiniate, Alis Hughes, REGISTRY Investigators of the European Huntington's Disease Network2, Daniel Mark Farewell, Peter Holmans, Lesley Jones, Raphael M. Bonelli et al. · 2018 · Journal of Huntington s Disease
- Uncovering an allosteric mode of action for a selective inhibitor of human Bloom syndrome proteinChen, Xiangrong, Ali, Yusuf I, Fisher, Charlotte EL, Arribas-Bosacoma, Raquel, Rajasekaran, Mohan B, Williams, Gareth, Walker, Sarah, Booth, Jessica R, Hudson, Jessica JR, Roe, S Mark et al. · 2021 · eLife
- Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible ElectroporationXin Long, Anna Dai, Teng Huang, Wenhao Niu, Luoxia Liu, Hui Xu, Tao Yin, Tianan Jiang, Shuguo Sun, Ping Lei et al. · 2023 · ACS Nano
- Targeting DNA Damage Response and Repair Genes to Enhance Anticancer Immunotherapy: Rationale and Clinical ImplicationGiuseppe Lamberti, Elisa Andrini, Monia Sisi, Alessandro Di Federico, Biagio Ricciuti · 2020 · Future Oncology
- Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancersShaoyang Zhang, Xiufeng Liu, Saleh Abdulmomen Ali Mohammed, Hui Li, Wanhua Cai, Wen xian Guan, Daiyun Liu, Yanli Wei, Dade Rong, Ying Fang et al. · 2021 · Autophagy
- Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract CancerAh‐Rong Nam, Mei Hua Jin, Ji Eun Park, Ju‐Hee Bang, Do‐Youn Oh, Yung‐Jue Bang · 2018 · Cancer Research and Treatment
- Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS OverproductionSofia Giacosa, Catherine Pillet, Irinka Séraudie, Laurent Guyon, Yann Wallez, Caroline Roelants, Christophe Battail, Bertrand Evrard, Frédéric Chalmel, Caroline Barette et al. · 2021 · Cancers
- Targeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapyKerry Silva McPherson, Dmitry M. Korzhnev · 2021 · RSC Chemical Biology
- ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombinationDoohyung Lee, Katja Apelt, Seong-Ok Lee, Hsin‐Ru Chan, Martijn S. Luijsterburg, Justin W. C. Leung, Kyle M. Miller · 2022 · Nucleic Acids Research
- Molecular and Cellular Functions of the Warsaw Breakage Syndrome DNA Helicase DDX11Francesca M. Pisani, Ettore Napolitano, Luisa M. R. Napolitano, Silvia Onesti · 2018 · Genes
- Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomasRüveyda Dok, Marieke Bamps, Mary Glorieux, Peihua Zhao, Anna A. Sablina, Sandra Nuyts · 2019 · International Journal of Cancer
- Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment ApproachesKaram Khaddour, Lucas Maahs, Ana Maria Avila Rodriguez, Yazan Maamar, Sami Samaan, George Ansstas · 2021 · Cancers
- Exploiting radiation immunostimulatory effects to improve glioblastoma outcomeHala Awada, François Paris, Claire Pecqueur · 2022 · Neuro-Oncology
- Transcriptional responses to DNA damageSilva, Erica, Ideker, Trey · 2019 · DNA repair
- Ubiquitination at the interface of tumor viruses and DNA damage responsesJoseph M. Dybas, Christin Herrmann, Matthew D. Weitzman · 2018 · Current Opinion in Virology